Skip to content

effective management of mootrashmari(renal stone) through ayurveda

Role of Varuna-shigru Kwatha and Ashmarihara Kwatha in the management of mootrashmari w.s.r to urolithiasis - Renal Stone

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2016/01/006563
Enrollment
45
Registered
2016-01-27
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients having signs and symptoms of Mootrashmari(Urolithiasis) as per Modern and Ayurveda considering Doshic variance of Mootrashmari.

Interventions

Intervention1: Varunshigru Kwatha with Yavakshar Prakshep: In group A 40ml Varunshigru Kwatha with 2gm yavakshar as Prakshep is given orally for twice a day for 30 days. Intervention2: Ashmarihara Kwa

Sponsors

INSTITUTE FOR POST GRADUATION TEACHING AND RESEARCH IN AYURVEDA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Pain in the renal angle & loin region, radiating towards groin. 2.Renal & Bladder Stone size up to 20mm. 3.Ureteric Stone size up to 10mm 4.Radiographic and?or USG evidence of the stone. 5.Crystals of stone. 6.Urolithiatic patientsvwith controlled Hypertantion and Diabetic mellitus.

Exclusion criteria

Exclusion criteria: 1.Renal failure. 2.Gross Hydronephrosis. 3.Acute pain abdomen. 4.Cases which requires surgical intervention. 5.sever haematuria. 6.Renal & Bladder Stone size > 20mm 7.Ureteric Stone size > 10mm 8.Known case of Malignancy. 9.Known case of Tuberculosis. 10.Known case of HIV, VDRL & Hepatitis-B Positive.

Design outcomes

Primary

MeasureTime frame
1 Removal of urolithiasis 2 Sign and Symptoms of Mootrashmari will reduce with treatment.Timepoint: 60 days

Secondary

MeasureTime frame
improvement in quality of life prevent the recurrence of urolithiasisTimepoint: 1 month

Countries

India

Contacts

Public ContactDr SKGupta

IPGT RA

drskgupta17@gmail.com9428317639

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026